Trial Profile
Clinical results and side-effects observation of esophageal squamous cell carcinomas treated with preoperative concurrent chemoradiotherapy based on cisplatin associated with tegafur gimeracil oteracil potassium capsule
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 19 Jun 2014 New trial record